Bryxta 300 mg Injection

Get a Price/Quote

MOQ : 20 Pieces

Bryxta 300 mg Injection Specification

Origin of Medicine
INDIA

Physical Form
Liquid

Recommended For
DOCTOR

Quantity
20 Pieces

Container Type
Vial

Colour
Clear

Brand Name
Bryxta

Prescription Required
Yes

Route of Administration
Intravenous

Bryxta 300 mg Injection Trade Information

Minimum Order Quantity
20 Pieces

Delivery Time
1 Week

About Bryxta 300 mg Injection

Bryxta 300 mg Injection is a targeted anti-cancer therapy designed to combat various malignancies, including colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This innovative treatment utilizes a monoclonal antibody that specifically inhibits vascular endothelial growth factor (VEGF), a protein that plays a crucial role in tumor growth and vascularization. By blocking VEGF, Bryxta helps to starve tumors of the blood supply they need to grow, making it an essential part of a comprehensive cancer treatment plan. It is typically administered in conjunction with other medications to enhance efficacy and improve patient outcomes. As with any medication, it is important to be aware of potential side effects, which may include fatigue, nausea, and increased risk of bleeding. Patients should consult their healthcare provider for personalized advice and monitoring while undergoing treatment with Bryxta. Overall, Bryxta 300 mg Injection represents a significant advancement in cancer care, offering hope to those battling these challenging diseases.

Key Features of Bryxta 300 mg Injection

Bryxta 300 mg Injection is a clear, liquid pharmaceutical solution delivered intravenously. Packaged in vials, it ensures precise dosing and quality preservation. Originating in India, it is intended only for professionals handling prescription medications, meeting rigorous healthcare and export criteria. Its formulation and packaging make it suitable for trade and clinical supply chains.

Usage Guidelines and Storage

This injection must be administered by qualified healthcare providers such as doctors. It should be stored as per the recommended medical standards to maintain efficacy. Users must ensure the product remains in its original vial until use and follow proper handling protocols during distribution or export to preserve its safety profile.

FAQ's of Bryxta 300 mg Injection:

Q: How should Bryxta 300 mg Injection be administered?

A: Bryxta 300 mg Injection is intended for intravenous use only and must be administered by a qualified healthcare professional such as a doctor to ensure safety and correct dosage.

Q: What is the recommended storage and handling process for Bryxta 300 mg Injection?

A: The injection should be stored in its original vial, in a cool and dry place away from direct light and heat. Proper medical-grade protocols must be followed to maintain product integrity during transportation and storage.

Q: When is it appropriate to use Bryxta 300 mg Injection?

A: This medication is prescribed by doctors for specific medical conditions requiring intravenous administration. It is not for self-use and should be used under professional medical supervision in hospital or clinic settings.

Q: Where is Bryxta 300 mg Injection manufactured and distributed?

A: Bryxta 300 mg Injection is manufactured in India and is made available to medical institutions and authorized distributors, exporters, suppliers, traders, and wholesalers throughout India.

Q: What are the benefits of using Bryxta 300 mg Injection?

A: The medication offers a reliable, standardized solution for intravenous treatment, ensuring consistent therapeutic outcomes in professional healthcare environments.

Q: Who is authorized to supply or receive Bryxta 300 mg Injection?

A: Only licensed medical professionals and authorized organizations-such as doctors, distributors, exporters, suppliers, traders, and wholesalers-can supply or receive this prescription-only medication.

Tell us about your requirement